Related Content
Search Google Scholar for:
|
PNAS 108 (10): 4093-4098
Copyright © 2011 by the National Academy of Sciences.
Wounding mobilizes hair follicle stem cells to form tumors
Sunny Y. Wong
Jeremy F. Reiter1
Department of Biochemistry and Biophysics, Cardiovascular Research Institute, University of California, San Francisco, CA 94158
View larger version (109K):
[in this window]
[in a new window]
|
Fig. 1. SmoM2-expressing bulge or SHG-derived cells form superficial BCC-like tumors at sites of injury. (A) Intact K15:SmoM2 dorsal skin, 11 wk after oncogene induction, displays largely normal IFE and telogen hair follicles, similar to wild-type skin. (B) Magnified view of the boxed area in A, showing a follicle with a focally hyperplastic bulge (arrow). (C) RU486-induced K15:SmoM2 skin, 10 wk after wounding, possesses superficial BCC-like tumors (arrows) at the site of the healed wound (dashed line). Control skin does not form tumors after wounding. (D) Magnified view of BCC-like tumors in C. (E) β-Gal staining indicating that K14-CreERT and K15-CrePR1 exhibit largely reciprocal domains of activity, irrespective of SmoM2 expression, 3 d post induction. (F) Quantitation of β-Gal+ cell location 3 d after induction. (G) Intact K14:SmoM2:LacZ dorsal skin, 11 wk after oncogene induction, contains extensive IFE hyperplasia and BCC-like downgrowths (arrows), without obvious involvement of the bulge (Inset). (H) K14:SmoM2:LacZ skin, 10 wk after wounding, exhibits BCC-like downgrowths equally abundant at the healed wound site (dashed line) and in intact skin. (I) Magnified view of tumors from wounded K14:SmoM2:LacZ skin. (J) Quantitation of BCC-like neoplastic downgrowths, either at the healed wound site or in intact skin (*P = 0.017). G–I were stained for LacZ expression. In non–LacZ-expressing control animals, no consistent β-Gal staining was detected (data not shown).
|
|
View larger version (87K):
[in this window]
[in a new window]
|
Fig. 2. Wounding induces the migration of bulge and SHG-derived cells into sites of injury. (A) β-Gal+ bulge and SHG-derived cells from K15:LacZ and K15:SmoM2:LacZ skin migrate into the epithelial tongue (asterisk) at the leading edge of the contracting wound, 3 d after injury. (Right) Magnified views of the boxed areas. (B) β-Gal staining of healed dorsal skin, 10 wk after wounding, indicates that labeled cells infrequently persist in K15-CrePR1 skin. (Right) Infrequently retained bulge or SHG-derived β-Gal+ cells contribute normally to the healed epithelium in the absence of oncogene expression but form tumors in the presence of SmoM2. (C) Immunofluorescence staining of normal telogen follicles (Left), IFE-derived tumors of K14:SmoM2 skin (Center), and wound-induced tumors of K15:SmoM2 skin (Right).
|
|
View larger version (55K):
[in this window]
[in a new window]
|
Fig. 3. SmoM2-expressing bulge and SHG cells fail to activate robust Hh signaling. (A) In situ staining for Gli1 in wound-induced tumors from K15:SmoM2 skin. (B) β-Gal staining reveals that cells that had undergone K15-CrePR1-mediated recombination are retained in the bulge and SHG of unwounded skin for at least 10 wk, irrespective of SmoM2 expression. (C) In situ staining for Gli1 in wild-type telogen skin (Left) and unwounded K15:SmoM2 skin (Right). Arrow indicates the site of normal Gli1 expression near the SHG and dermal papilla. (D) Gli1 is modestly up-regulated at a site of focal hyperplasia in the bulge of unwounded K15:SmoM2 skin (arrowhead). (E) Immunofluorescence staining for the YFP tag of SmoM2 and Gli2 in K15:SmoM2 wound-induced tumors (Top), in unwounded K15:SmoM2 follicles (Middle), and in non-SmoM2-expressing control follicles (Bottom). Arrows indicate the SmoM2-expressing cells from unwounded K15:SmoM2 follicles (blue, DAPI).
|
|
View larger version (45K):
[in this window]
[in a new window]
|
Fig. 4. Bulge or SHG-derived BCC-like tumors are induced by incisional or excisional wounding but not by depilation. (A) β-Gal staining indicates that bulge and SHG-derived cells that had undergone K15-CrePR1-mediated recombination contribute to cells of the lower anagen bulb in hyperplastic follicles from depilated K15:SmoM2:LacZ skin. (B Upper) Follicles of K15:SmoM2 skin are grossly normal 10 wk after depilation. Note that anagen hair follicles had subsequently progressed to telogen without developing aberrations, aside from occasional focal hyperplasia (Right, arrows). (Lower) β-Gal staining demonstrates that bulge and SHG cells that had undergone K15-CrePR1-mediated recombination are retained in K15:SmoM2 skin 10 wk after depilation. (C) BCC-like tumors arise from healed excisional wound sites of K15:SmoM2 skin injured 5 wk after induction of SmoM2. (D) Tumors (arrows) arise at the healed incisional wound junction of K15:SmoM2 mice 10 wk after injury but do not form in healed control K15-CrePR1 skin.
|
|
|
|
